National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

From the 1/14/2022 release of VAERS data:

Found 62,317 cases where Vaccine is DTAP

Government Disclaimer on use of this data



Case Details (Reverse Sorted by Appearance Date)

This is page 3 out of 3,116

Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22   next


VAERS ID: 1953625 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Foreign  
Vaccinated:2021-06-01
Onset:2021-08-22
   Days after vaccination:82
Submitted: 0000-00-00
Entered: 2021-12-16
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (UNKNOWN)) / UNKNOWN MANUFACTURER PV46696 / 2 - / OT
DTAP: DTAP (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK - / OT

Administered by: Other       Purchased by: ?
Symptoms: COVID-19, Investigation, Live birth, Maternal exposure during breast feeding, Maternal exposure during pregnancy, Parosmia, SARS-CoV-2 test, Scan
SMQs:, Taste and smell disorders (narrow), Pregnancy, labour and delivery complications and risk factors (excl abortions and stillbirth) (narrow), Neonatal exposures via breast milk (narrow), Normal pregnancy conditions and outcomes (narrow), Infective pneumonia (broad), Opportunistic infections (broad), COVID-19 (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: FOLIC ACID
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Test Name: Investigation; Result Unstructured Data: normal; Test Name: COVID-19 virus test; Test Result: Negative ; Test Name: Scan; Result Unstructured Data: normal
CDC Split Type: GBSA2021SA407040

Write-up: Patient was exposed to the vaccine Second-trimester (13-28 weeks).; Maternal exposure during breast feeding; Metallic smell; Live birth; SARS-CoV-2 infection; Initial information was received on 05-Dec-2021 regarding an unsolicited valid serious case from consumer/non-health care professional via the(under reference GB-MHRA-YCVM-202106012154148310-A9JHT) This case involves a 37 year old female patient (158 cm) who experienced metallic smell (parosmia), severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) infection (COVID-19) after receiving DIPHTHERIA, TETANUS, AC PERTUSSIS AND IPV VACCINE and COVID-19 VACCINE NRVV AD (CHADOX1 NCOV-19) (COVID-19 VACCINE ASTRAZENECA) during the second trimester (Maternal exposure during pregnancy, live birth and Maternal exposure during breast feeding) Data regarding this pregnancy were received retrospectively, i.e., after pregnancy outcome was known. The date of last menstrual period was reported as 03-Jan-2021. The estimated due date was 03-Oct-2021. The patient''s medical treatment(s), vaccination(s) and family history were not provided. Patient has not had symptoms associated with COVID-19 Concomitant medications included FOLIC ACID 400 microgram for Folic acid supplementation On an unknown date, the patient received a dose of suspect DIPHTHERIA, TETANUS, AC PERTUSSIS AND IPV VACCINE produced by unknown manufacturer lot number not reported via unknown route in unknown administration site for prophylactic vaccination. On 01-Jun-2021, the patient received a second dose of suspect COVID-19 VACCINE ASTRAZENECA not produced by Sanofi Pasteur lot PV46696 via unknown route in unknown administration site for prophylactic vaccination. Patient was exposed to the vaccine in Second-trimester (13-28 weeks). On 22-Aug-2021 the patient developed a serious SARS-COV-2 infection (COVID-19) (unknown latency) following the administration of DIPHTHERIA, TETANUS, AC PERTUSSIS AND IPV VACCINE and 2 months 21 days following the administration of COVID-19 VACCINE ASTRAZENECA. On 31-Aug-2021, the event COVID-19 recovered. On an unknown date, the patient had maternal exposure during pregnancy, second trimester following the administration of DIPHTHERIA, TETANUS, AC PERTUSSIS AND IPV VACCINE and COVID-19 VACCINE ASTRAZENECA. On 03-Oct-2021 the patient had given live birth (unknown latency) following the administration of DIPHTHERIA, TETANUS, AC PERTUSSIS AND IPV VACCINE and 4 months 2 days following the administration of COVID-19 VACCINE ASTRAZENECA. On 10-Nov-2021 the patient developed a serious metallic smell (parosmia) (unknown latency) following the administration of DIPHTHERIA, TETANUS, AC PERTUSSIS AND IPV VACCINE and 5 months 9 days following the administration of COVID-19 VACCINE ASTRAZENECA. The patient was on breast feeding (Maternal exposure during breast feeding (unknown latency). All events were assessed as medically significant. Patient was not enrolled in clinical trial. Patient did not think vaccination had an adverse effect on any aspect of the pregnancy Relevant laboratory test results included: Investigation and Scan was [normal] SARS-CoV-2 test - On an unknown date: Negative It was not reported if the patient received a corrective treatment for the events parosmia and COVID-19 At the time of report, the event parosmia was not recovered Additionally, the outcome of the pregnancy was reported as Live Birth There will be no information available on the batch number for this case.; Sender''s Comments: This case concerns 37-year-old pregnant female patient who had parosmia and COVID-19 after vaccination with DIPHTHERIA, TETANUS, AC PERTUSSIS AND IPV VACCINE (unknown manufacturer) and COVID-19 VACCINE ASTRAZENECA (other manufacturer) during the second trimester (Maternal exposure during pregnancy, live birth and Maternal exposure during breast feeding). The time to onset is compatible with COVID-19 VACCINE. Details of previous pregnancies: Baby is born. Concomitant medications included FOLIC ACID. Details of scans or investigations: All fine. Additional information regarding patient''s condition at the time of vaccination would be needed for complete assessment of the case. Based upon the reported information, the role of individual vaccine cannot be assessed.


VAERS ID: 1950393 (history)  
Form: Version 2.0  
Age: 3.0  
Sex: Male  
Location: Kentucky  
Vaccinated:2021-12-06
Onset:2021-12-06
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-12-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (INFANRIX) / GLAXOSMITHKLINE BIOLOGICALS D2KX9 / UNK - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Expired product administered
SMQs:, Medication errors (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USGLAXOSMITHKLINEUS202125

Write-up: received a dose of Infanrix that had expired; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 3-year-old male patient who received DTPa (Infanrix) (batch number D2KX9, expiry date 23rd November 2021) for prophylaxis. Co-suspect products included dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 6th December 2021, the patient received Infanrix and Infanrix Pre-Filled Syringe Device. On 6th December 2021, unknown after receiving Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The reporter reported that a patient received a dose of Infanrix that had expired ,which led to expired vaccine used. The reporter consented to follow up.


VAERS ID: 1950830 (history)  
Form: Version 2.0  
Age: 54.0  
Sex: Unknown  
Location: Michigan  
Vaccinated:2021-12-06
Onset:2021-12-06
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-12-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DT: DT ADSORBED (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK - / OT
DTAP: DTAP (NO BRAND NAME) / UNKNOWN MANUFACTURER - / UNK - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Wrong product administered
SMQs:, Medication errors (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USSA2021SA412690

Write-up: A patient accidentally received a DT vaccine instead of the age appropriate Tdap vaccine with no AE; Initial information regarding an unsolicited valid non-serious case was received from a health care professional via Agency (Reference number- 00888053) and transmitted to Sanofi on 07-Dec-2021. This case involves a 54 year old and unknown gender patient who was accidentally received a DIPHTHERIA AND TETANUS TOXOIDS (dt) vaccine instead of the age appropriate DIPHTHERIA, TETANUS AND ACELLULAR PERTUSSIS VACCINE (tdap) (wrong product administered). The patient''s medical history, medical treatment(s), vaccination(s), concomitant medication(s) and family history were not provided. On 06-Dec-2021, the patient received a dose of suspect DIPHTHERIA AND TETANUS TOXOIDS produced by unknown manufacturer (batch number and expiry not reported) via unknown route in unknown administration site for prophylactic vaccination. It was a case of an actual medication error due to wrong product administered (latency same day). It was reported "Caller states that a 54 year old patient accidentally received a DT vaccination in the office on 06DEC2021 instead of the age appropriate Tdap vaccine. Caller states that she must attend to a patient and asked for the phone number for Medical Information so that she could call back to provide more information related to this occurrence." No other adverse event was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder''s compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. There will be no information available on the batch number for this case.


VAERS ID: 1952226 (history)  
Form: Version 2.0  
Age: 4.0  
Sex: Female  
Location: Alaska  
Vaccinated:2021-12-09
Onset:2021-12-10
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-12-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (INFANRIX) / GLAXOSMITHKLINE BIOLOGICALS 7EC55 / 4 LL / IM

Administered by: Private       Purchased by: ?
Symptoms: Erythema, Oedema peripheral, Skin swelling, Skin warm
SMQs:, Cardiac failure (broad), Anaphylactic reaction (broad), Angioedema (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Hypersensitivity (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations: Crying, abnormal behavior, grimacing to DTaP
Other Medications: clonidine, vitamin D3, vitamin C, B12, Omega #
Current Illness: Puncture wound to right sole, URI
Preexisting Conditions: Spinocerebellar ataxia, asthma, developmental and speech delay, sleep disorder, strabismus
Allergies: methylphenidate, guanfacine
Diagnostic Lab Data: See in ED 12/10/2021
CDC Split Type:

Write-up: Swollen, hot, red skin 8 cm in diameter covering most of child''s anterior thigh from proximal thigh to just above knee; no fever


VAERS ID: 1952286 (history)  
Form: Version 2.0  
Age: 0.33  
Sex: Female  
Location: California  
Vaccinated:2021-12-07
Onset:2021-12-07
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-12-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (INFANRIX) / GLAXOSMITHKLINE BIOLOGICALS 7EC55 / 2 RL / IM
HIBV: HIB (ACTHIB) / SANOFI PASTEUR UJ574AAA / 2 RL / IM
IPV: POLIO VIRUS, INACT. (IPOL) / SANOFI PASTEUR T1D481M / 2 LL / IM
PNC13: PNEUMO (PREVNAR13) / PFIZER/WYETH EJ4562 / 2 LL / IM
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS AB3BR / 2 MO / PO

Administered by: Public       Purchased by: ?
Symptoms: Product storage error
SMQs:, Medication errors (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: NONE
Current Illness: NONE
Preexisting Conditions: GERD
Allergies: NONE
Diagnostic Lab Data: NONE
CDC Split Type:

Write-up: PATIENT WAS GIVEN 2ND DOSE OF IPOL AT 4 MONTH WELL BABY EXAM ON 12/7/2021. THIS DOSE WAS INVOLVED IN A TEMPERATURE EXCURSION ON 11/30/2021 AND DISCOVERED BY STAFF ON 11/13/2021. THIS PUNCTURED VIAL OF IPOL REACHED A MAX TEMPERATURE OF 10.47 CELSIUS NOT EXCEEDING 2 CUMULATIVE HOURS. WE REACHED OUT TO MANUFACTURER ON 12/14/2021 TO DETERMINE STABILITY WITH CASE NUMBER 00899982. BEST PRACTICES AS SUGGESTED BY MANUFACTURER INVOLVES RE-VACCINATING PATIENT. MD NOTIFIED OF INCIDENT ON 12/15/2021.


VAERS ID: 1948154 (history)  
Form: Version 2.0  
Age: 27.0  
Sex: Female  
Location: Unknown  
Vaccinated:2021-12-09
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-12-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (DAPTACEL) / SANOFI PASTEUR - / UNK - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Product administered to patient of inappropriate age, Wrong product administered
SMQs:, Medication errors (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: DTaP administered to patient instead of intended Tdap. No patient harm identified.


VAERS ID: 1948284 (history)  
Form: Version 2.0  
Age: 28.0  
Sex: Female  
Location: California  
Vaccinated:2016-11-11
Onset:2016-11-11
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-12-14
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (INFANRIX) / GLAXOSMITHKLINE BIOLOGICALS 9Z525 / UNK LA / IM

Administered by: Public       Purchased by: ?
Symptoms: Abdominal pain upper, Accident, Cystitis interstitial, Disability, Dyspepsia, Fatigue, Feeling abnormal, Impaired healing, Impaired work ability, Inflammation, Insomnia, Intervertebral disc protrusion, Neurological examination abnormal, Neurotransmitter level altered, Urinary tract infection
SMQs:, Acute pancreatitis (broad), Dementia (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Accidents and injuries (narrow), Gastrointestinal nonspecific dysfunction (narrow), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Immune-mediated/autoimmune disorders (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Zoloft 12mg
Current Illness:
Preexisting Conditions: IBS
Allergies: Gluten, dairy, eggs, nuts, certain antibiotics such as macrobid, levaquin, z pac
Diagnostic Lab Data: 02/2019 received neurological testing from functional medicine doctor who saw neurotransmitter metabolites were extremely high
CDC Split Type:

Write-up: Within 15 minutes of receiving injection, developed severe fatigue and brain fog as well as very strong stomach ache. Fatigue and brain fog never lifted but progressively got worse. Digestion became much worse. Chronic UTI?s began March 2017 and developed interstitial cystitis by fall 2017. By 2018 the neurological fatigue was severe and insomnia became unbearable. Had an accident resulting in bulging discs that never healed because neurological system was so fatigued and burdened. Severe systemic inflammation did not allow healing. Was placed on disability Nov 2018, was on it for one full year. Have not worked full time since.


VAERS ID: 1943515 (history)  
Form: Version 2.0  
Age: 40.0  
Sex: Female  
Location: Texas  
Vaccinated:2021-12-06
Onset:2021-12-14
   Days after vaccination:8
Submitted: 0000-00-00
Entered: 2021-12-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (DAPTACEL) / SANOFI PASTEUR U6923AA / UNK RA / IM

Administered by: Work       Purchased by: ?
Symptoms: Mass, Pain, Swelling
SMQs:, Anaphylactic reaction (broad), Angioedema (broad), Haemodynamic oedema, effusions and fluid overload (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: azathioprine, hydroxychloroquine, estridiol, medroxyprogesterone, amlodipine
Current Illness: none
Preexisting Conditions: Mixed connective tissue disease, HTN
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Localized swelling with formation of large, well circumscribed mass and associated pain (Adacel)


VAERS ID: 1945333 (history)  
Form: Version 2.0  
Age: 4.0  
Sex: Male  
Location: California  
Vaccinated:2021-11-30
Onset:2021-11-30
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-12-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (INFANRIX) / GLAXOSMITHKLINE BIOLOGICALS 7EC55 / 5 LA / IM
FLU4: INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) / GLAXOSMITHKLINE BIOLOGICALS UT7347MA / UNK RA / IM
IPV: POLIO VIRUS, INACT. (IPOL) / SANOFI PASTEUR T1E872M / 4 LA / IM
MMR: MEASLES + MUMPS + RUBELLA (MMR II) / MERCK & CO. INC. T025930 / 2 LA / SC
VARCEL: VARICELLA (VARIVAX) / MERCK & CO. INC. U019904 / 2 RA / SC

Administered by: Private       Purchased by: ?
Symptoms: Dizziness, Loss of consciousness, Seizure like phenomena
SMQs:, Torsade de pointes/QT prolongation (broad), Hyperglycaemia/new onset diabetes mellitus (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Convulsions (narrow), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Vestibular disorders (broad), Hypotonic-hyporesponsive episode (broad), Generalised convulsive seizures following immunisation (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type:

Write-up: Patient felt dizzy, passed out for few seconds and had a seizure likely activity and recovered well in the room, pt is sent to the ER and was discharge home from the ER


VAERS ID: 1945538 (history)  
Form: Version 2.0  
Age: 2.0  
Sex: Female  
Location: Arizona  
Vaccinated:2021-12-08
Onset:2021-12-08
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-12-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (DAPTACEL) / SANOFI PASTEUR C5774BA / 4 LL / IM

Administered by: Private       Purchased by: ?
Symptoms: Injection site urticaria, Urticaria
SMQs:, Anaphylactic reaction (broad), Angioedema (narrow), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: none
Current Illness: Dog bite 13 days prior to vaccination, no antibiotics given and healing well at time of vaccination.
Preexisting Conditions: None
Allergies: Possible allergies to cephalexin, ibuprofen, and acetaminophen
Diagnostic Lab Data: No testing, evaluation in the office by MD 12/13/2021.
CDC Split Type:

Write-up: Hives starting within 2 hours of vaccination initially near vaccination site followed by generalized spread.


VAERS ID: 1942551 (history)  
Form: Version 2.0  
Age: 4.0  
Sex: Male  
Location: Illinois  
Vaccinated:2021-12-11
Onset:2021-12-12
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-12-12
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (DAPTACEL) / SANOFI PASTEUR - / 5 UN / IM
FLU4: INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) / GLAXOSMITHKLINE BIOLOGICALS - / N/A UN / IM
IPV: POLIO VIRUS, INACT. (IPOL) / SANOFI PASTEUR - / 4 UN / IM
MMR: MEASLES + MUMPS + RUBELLA (MMR II) / MERCK & CO. INC. - / 2 UN / IM
VARCEL: VARICELLA (VARIVAX) / MERCK & CO. INC. - / 2 UN / IM

Administered by: Public       Purchased by: ?
Symptoms: Dysstasia, Electroencephalogram, Endotracheal intubation, Muscle twitching, Retching, Status epilepticus
SMQs:, Angioedema (broad), Systemic lupus erythematosus (broad), Convulsions (narrow), Dyskinesia (broad), Dystonia (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Generalised convulsive seizures following immunisation (narrow), Respiratory failure (broad), Hypoglycaemia (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: None
Current Illness: Viral respiratory illness 1 week prior to vaccination
Preexisting Conditions: None
Allergies: None
Diagnostic Lab Data: EEG currently running 12/12/21
CDC Split Type:

Write-up: Patient received vaccines at 10am on 12/11/21. At midnight on 12/12/21 patient began making a gagging noise and had facial twitching. Mother of patient brought him to ED where he could not stand and had extremity twitching. Patient was intubated for status epilepticus and transferred to Medical Center.


VAERS ID: 1941655 (history)  
Form: Version 2.0  
Age: 11.0  
Sex: Female  
Location: Texas  
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-12-11
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (INFANRIX) / GLAXOSMITHKLINE BIOLOGICALS UNK / 1 - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Product administered to patient of inappropriate age, Wrong product administered
SMQs:, Medication errors (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USGLAXOSMITHKLINEUS2021AM

Write-up: Infanrix (DTaP) dose given instead of TDaP; Infanrix (DTaP) given to 11 year old; This case was reported by a other health professional via sales rep and described the occurrence of wrong vaccine administered in a 11-year-old female patient who received DTPa (Infanrix) for prophylaxis. Co-suspect products included dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On an unknown date, the patient received the 1st dose of Infanrix .5 ml and Infanrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced wrong vaccine administered and inappropriate age at vaccine administration. On an unknown date, the outcome of the wrong vaccine administered and inappropriate age at vaccine administration were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were reported as follows: The age at vaccination was not reported. Infanrix (DTaP), one .5ml dose given to this 11 year old patient instead of TDaP; which led to wrong vaccine administered and inappropriate age at vaccine administration. The reporter consented to follow up.


VAERS ID: 1941669 (history)  
Form: Version 2.0  
Age:   
Sex: Unknown  
Location: Michigan  
Vaccinated:2021-12-02
Onset:0000-00-00
Submitted: 0000-00-00
Entered: 2021-12-11
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (INFANRIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK - / -
DTAPHEPBIP: DTAP + HEPB + IPV (PEDIARIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK - / -
FLU4: INFLUENZA (SEASONAL) (FLULAVAL QUADRIVALENT) / GLAXOSMITHKLINE BIOLOGICALS - / UNK - / -
HEP: HEP B (ENGERIX-B) / GLAXOSMITHKLINE BIOLOGICALS - / UNK - / -
HEPA: HEP A (HAVRIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK - / -
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK - / -
TDAP: TDAP (BOOSTRIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Product storage error
SMQs:, Medication errors (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USGLAXOSMITHKLINEUS202125

Write-up: Possible administration of vaccines after temperature excursion; This case was reported by a other health professional via call center representative and described the occurrence of incorrect storage of drug in an unspecified number of patients who received DTPa (Infanrix) for prophylaxis. Co-suspect products included dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis, HAV (Havrix) for prophylaxis, hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis, HBV (Engerix B) for prophylaxis, hepatitis B vaccine pre-filled syringe device (Engerix B Pre-Filled Syringe Device) injection syringe for prophylaxis, DTPa-HBV-IPV (Pediarix) for prophylaxis, dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis, Flu Seasonal QIV Quebec (FluLaval Quadrivalent 2021-2022 season) for prophylaxis, flu seasonal qiv quebec pre-filled syringe device (Flulaval Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis, DTPa (Reduced antigen) (Boostrix) for prophylaxis, Rota (Rotarix lyophilized formulation) for prophylaxis and rotavirus vaccine oral applicator device (Rotarix Oral Applicator Device) oral applicator for prophylaxis. On 2nd December 2021, the patient received Infanrix, Infanrix Pre-Filled Syringe Device, Havrix, Havrix Pre-Filled Syringe Device, Engerix B, Engerix B Pre-Filled Syringe Device, Pediarix, Pediarix Pre-Filled Syringe Device, FluLaval Quadrivalent 2021-2022 season, Flulaval Tetra Pre-Filled Syringe Device, Boostrix, Rotarix lyophilized formulation and Rotarix Oral Applicator Device. On an unknown date, unknown after receiving Infanrix, Infanrix Pre-Filled Syringe Device, Havrix, Havrix Pre-Filled Syringe Device, Engerix B, Engerix B Pre-Filled Syringe Device, Pediarix, Pediarix Pre-Filled Syringe Device, FluLaval Quadrivalent 2021-2022 season, Flulaval Tetra Pre-Filled Syringe Device, Boostrix, Rotarix lyophilized formulation and Rotarix Oral Applicator Device, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The age at vaccination was not reported. The medical assistant reported that, a below temperature excursion of negative 2.0 degree celcius for 6 minutes for Infanrix, Havrix, Engerix B, Pediarix, Flulaval QIV, Rotarix, Boostrix, which led to incorrect storage of drug. No priors excursions. The reporter was not completely sure if any of their patients might have been vaccinated with any of these vaccines. No details from patient or patients or any other details provided as reporter was not sure this happened or not. The reporter consented to follow up.


VAERS ID: 1941970 (history)  
Form: Version 2.0  
Age: 0.08  
Sex: Male  
Location: Florida  
Vaccinated:2021-11-08
Onset:2021-11-08
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-12-11
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (DAPTACEL) / SANOFI PASTEUR C5774CA / UNK LL / OT
HIBV: HIB (ACTHIB) / SANOFI PASTEUR - / UNK - / OT
IPV: POLIO VIRUS, INACT. (IPOL) / SANOFI PASTEUR - / UNK - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Medication error, No adverse event, Product administered to patient of inappropriate age, Wrong product administered
SMQs:, Medication errors (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: ROTAVIRUS VACCINE; PREVNAR
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USSA2021SA404449

Write-up: The patient received Daptacel and not Adacel with no adverse event; four week old patient received Daptacel, Ipol, and ActHIB with no adverse event; Initial information received on 30-Nov-2021 regarding an unsolicited valid non-serious case from a consumer/non-health care professional via Media Information (under reference 00878770). This case involves a 34 days old male patient who received DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL] instead of Adacel (wrong product administered), also received HIB (PRP/T) VACCINE [ACT-HIB] and IPV (VERO) [IPOL] (Product administered to patient of inappropriate age). The patient''s medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Merck ROTAVIRUS VACCINE and Pfizer PNEUMOCOCCAL VACCINE CONJ 7V (CRM197) (PREVNAR) [lot and expiration date were not reported] via unknown route in an unknown administration site for prophylactic vaccination. On 08-Nov-2021, the patient received a dose of suspect DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE (ORAL SOLUTION IN SINGLE-DOSE CONTAINER, Total, lot C5774CA and expiration date: 18-Sep-2022) via unknown route in an unknown administration site for prophylactic vaccination. On an unknown date, the patient received dose of suspect HIB (PRP/T) VACCINE and dose of suspect IPV (VERO) [lot number and expiration date were not reported] via unknown route in an unknown administration site for prophylactic vaccination It was a case of an actual medication error due to wrong vaccine administered and Inappropriate age at vaccine administration (same day latency). It was reported "A four week old patient received Daptacel and not Adacel, Ipol, and ActHIB and she would like to know how to proceed with the patient." At time of reporting, no adverse event reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder''s compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. There will be no information available on the batch number for IPOL and ACT-HIB.


VAERS ID: 1941971 (history)  
Form: Version 2.0  
Age: 0.08  
Sex: Male  
Location: Florida  
Vaccinated:2021-11-08
Onset:2021-11-08
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-12-11
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (DAPTACEL) / SANOFI PASTEUR UJ585AAA / UNK RL / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Medication error, No adverse event, Product administered to patient of inappropriate age
SMQs:, Medication errors (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: ROTAVIRUS VACCINE; PREVNAR
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USSA2021SA403444

Write-up: A four week old patient received Daptacel no AE; Initial information regarding an unsolicited valid non-serious case was received from a physician via a consumer/non-health care professional via Medical Information (MI) (Reference number- 00878868) and transmitted to Sanofi on 30-Nov-2021. This case involves a 4 week old male patient who was received DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE [DAPTACEL] (product administered to patient of inappropriate age). The patient''s medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included ROTAVIRUS VACCINE and PNEUMOCOCCAL VACCINE CONJ 7V (CRM197) (PREVNAR) for prophylactic vaccination. On 08-Nov-2021, the patient received a 0.5 mL dose of suspect DIPHTHERIA-15/TETANUS/5 AC PERTUSSIS VACCINE (lot UJ585AAA, expiry not reported) via intramuscular route in the right thigh for prophylactic vaccination. It was a case of an actual medication error due to Inappropriate age at vaccine administration (latency same day). It was reported "A four week old patient received Daptacel and not Adacel, Ipol, and ActHIB and she would like to know how to proceed with the patient. She states that e-mail is fine." No other adverse event was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder''s compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.


VAERS ID: 1940200 (history)  
Form: Version 2.0  
Age: 0.17  
Sex: Male  
Location: Florida  
Vaccinated:2021-12-07
Onset:2021-12-08
   Days after vaccination:1
Submitted: 0000-00-00
Entered: 2021-12-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (DAPTACEL) / SANOFI PASTEUR C5574CA / 1 LL / IM
IPV: POLIO VIRUS, INACT. (IPOL) / SANOFI PASTEUR T1E872M / 1 RL / IM
RV5: ROTAVIRUS (ROTATEQ) / MERCK & CO. INC. 1707496 / 1 MO / PO

Administered by: Private       Purchased by: ?
Symptoms: Body temperature increased, Condition aggravated, Irritability, Respiratory tract congestion, Sleep disorder, Vomiting
SMQs:, Acute pancreatitis (broad), Neuroleptic malignant syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Hostility/aggression (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: None
Current Illness: Congestion, sneezing
Preexisting Conditions: GERD
Allergies: NKA
Diagnostic Lab Data: None
CDC Split Type:

Write-up: Patient was very irritable, not sleeping, vomited x2, & had elevated temperature. These symptoms started 36 hrs after vaccines. Then 2 days after patient became more congested & started coughing. Highest temperature was 99.9 rectally.


VAERS ID: 1934827 (history)  
Form: Version 2.0  
Age: 1.25  
Sex: Male  
Location: Colorado  
Vaccinated:2021-12-02
Onset:2021-12-02
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-12-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (INFANRIX) / GLAXOSMITHKLINE BIOLOGICALS D2KX9 / 4 - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Expired product administered
SMQs:, Medication errors (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USGLAXOSMITHKLINEUS202124

Write-up: received an expired 4th dose of Infanrix; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 15-month-old male patient who received DTPa (Infanrix) (batch number D2KX9, expiry date 26th November 2021) for prophylaxis. Co-suspect products included dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 2nd December 2021, the patient received the 4th dose of Infanrix and Infanrix Pre-Filled Syringe Device. On 2nd December 2021, unknown after receiving Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: The patient''s date of birth was not provided. The reporter reported that patient received an expired dose of Infanrix, which led to expired vaccine used. The reporter did not consent to follow-up.


VAERS ID: 1936435 (history)  
Form: Version 2.0  
Age: 4.0  
Sex: Male  
Location: West Virginia  
Vaccinated:2021-11-05
Onset:2021-11-05
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-12-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (NO BRAND NAME) / UNKNOWN MANUFACTURER - / 5 LA / SYR
IPV: POLIO VIRUS, INACT. (NO BRAND NAME) / UNKNOWN MANUFACTURER - / 4 RA / SYR

Administered by: Private       Purchased by: ?
Symptoms: Emotional disorder, Injection site discolouration, Injection site erythema, Injection site extravasation, Injection site pruritus, Injection site reaction, Injection site scar, Injection site swelling, Injection site warmth
SMQs:, Extravasation events (injections, infusions and implants) (narrow), Haemodynamic oedema, effusions and fluid overload (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations: I don?t remember which vaccine it was. We called his doctor, when we were in the car after getting the vaccination, and told him
Other Medications: Childrens multi vitamin (equate), vitamin c
Current Illness:
Preexisting Conditions:
Allergies: None known at this time
Diagnostic Lab Data:
CDC Split Type:

Write-up: Mild swelling, warmth, and redness around the injection site, on the day he got the shot. The next day, the redness, heat, and swelling spread more. The tiny hole from the injection started looking more like a line instead of a dot. The night of November 6, the swelling, warmth, and redness spread. Covering his arm from top of shoulder down to his elbow. He also began to have a yellow colored ring (about the size of a donut) in the middle of the red area. The yellow colored part slowly started turning into small bubble like things. Some of those bubbles got much bigger. Some about the size of a dime. They were filled with clear yellow liquid. It was very itchy (according to my 4 year old). I very carefully put hydrocortisone ointment on it. A few minutes later, we noticed the largest bubble had started leaking the yellow fluid out and deflating a bit. When he did not improve, his doctor asked for us to bring him in to the office so he could look at it and see what was going on. He gave us an antibiotic for my son to take for 10 days. The bubbles slowly started to deflate and dry out that night. Even after the 10 days of medication, there was still scars from where the injection was given and where the bubbles had been. Ever since the day of vaccination , my child has had extremely emotional reactions, of all kinds, almost every day? which he wasn?t having frequently before this.


VAERS ID: 1936858 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Foreign  
Vaccinated:2016-08-30
Onset:2017-07-01
   Days after vaccination:305
Submitted: 0000-00-00
Entered: 2021-12-09
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (INFANRIX) / GLAXOSMITHKLINE BIOLOGICALS A21CC754A / UNK - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Bronchitis, Factor V deficiency, Hypercoagulation, Oedema mucosal, Rash, Von Willebrand's disease
SMQs:, Anaphylactic reaction (broad), Angioedema (broad), Congenital, familial and genetic disorders (narrow), Haemodynamic oedema, effusions and fluid overload (narrow), Hypersensitivity (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: INFANRIX; PREVENAR 13
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: DEGLAXOSMITHKLINEDE202124

Write-up: This case was reported by a consumer via regulatory authority and described the occurrence of von willebrand''s disease in a 19-month-old male patient who received DTPa (Infanrix) (batch number A21CC754A, expiry date unknown) for prophylaxis. Co-suspect products included dtpa vaccine pre-filled syringe device injection syringe for prophylaxis. Previously administered products included Infanrix with an associated reaction of no adverse event (received on 21st April 2016) and Prevenar 13 with an associated reaction of no adverse event (received on 21st April 2016). Concomitant products included DIPHTHERIA TOXOID + PERTUSSIS TOXOID ACELLULAR + TETANUS TOXOID (INFANRIX) and PNEUMOCOCCAL 13 VALENT CONJUGATE VACCINE (PREVENAR 13). On 30th August 2016, the patient received Infanrix (unknown) 1 dosage form(s) and dtpa vaccine pre-filled syringe device. On 1st July 2017, 305 days after receiving Infanrix and dtpa vaccine pre-filled syringe device, the patient experienced skin rash, bronchitis and mucosal swelling. On 1st February 2018, the patient experienced von willebrand''s disease (serious criteria GSK medically significant), factor v deficiency and thrombophilia. On an unknown date, the outcome of the von willebrand''s disease, skin rash, thrombophilia and mucosal swelling were recovered/resolved and the outcome of the factor v deficiency and bronchitis were not recovered/not resolved. It was unknown if the reporter considered the von willebrand''s disease, skin rash, factor v deficiency, bronchitis, thrombophilia and mucosal swelling to be related to Infanrix and dtpa vaccine pre-filled syringe device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follow: The age at vaccination was unknown. The PEI causality was reported as intermediate for von willebrand''s disease in association to Infanrix. The PEI causality was reported as unclassifiable for rash, factor v deficiency, bronchitis, thrombophilia and mucosal swelling in association to Infanrix. Note: Infanrix vaccine was captured as historical vaccine and concomitant vaccine as per dates. Initial information received from consumer via regulatory authority on 3rd December 2021: Skin rash, Von Willebrand-Juergens syndrome, factor V deficiency, thrombophilia, swelling of the mucous membranes.


VAERS ID: 1931238 (history)  
Form: Version 2.0  
Age: 11.0  
Sex: Male  
Location: California  
Vaccinated:2021-10-21
Onset:2021-10-21
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-12-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
DTAP: DTAP (INFANRIX) / GLAXOSMITHKLINE BIOLOGICALS 224CG / UNK - / -

Administered by: Unknown       Purchased by: ?
Symptoms: Product administered to patient of inappropriate age, Wrong product administered
SMQs:, Medication errors (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC Split Type: USGLAXOSMITHKLINEUS202124

Write-up: Administration of Infanrix instead of Boostrix; Pt of 11 years old received Infanrix; This case was reported by a nurse via call center representative and described the occurrence of wrong vaccine administered in a 11-year-old male patient who received DTPa (Infanrix) (batch number 224CG, expiry date 7th May 2023) for prophylaxis. Co-suspect products included dtpa vaccine pre-filled syringe device (Infanrix Pre-Filled Syringe Device) injection syringe for prophylaxis. On 21st October 2021, the patient received Infanrix and Infanrix Pre-Filled Syringe Device. On 21st October 2021, unknown after receiving Infanrix and Infanrix Pre-Filled Syringe Device, the patient experienced wrong vaccine administered and inappropriate age at vaccine administration. On an unknown date, the outcome of the wrong vaccine administered and inappropriate age at vaccine administration were unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional details were provided as follows: Nurse reported inadvertent administration of Infanrix instead of Boostrix to an 11 year old patient, which led to wrong vaccine administered and inappropriate age at vaccine administration. Health care professional gave consent for safety team to follow up The reporter consented to follow up.


Result pages: prev   1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22   next

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?EVENTS=ON&PAGENO=3&PERPAGE=20&ESORT=ENTRY-DATE&REVERSESORT=ON&VAX=DTAP


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166